Emergency care in a sudden individually significant blood pressure increase without clinically overt target organ damage: rationale for captopril use. Expert Council opinion

Expert Council opinion describes emergency care in a sudden individually significant blood pressure (BP) increase without clinically overt target organ damage. In the new guidelines of the Russian Society of Cardiology, the term “hypertensive urgency” was abolished, and the management of a sudden BP increase was changed. At the same time, a sudden individually significant BP increase may be accompanied by symptoms that reduce patients’ quality of life and ability to work. According to experts, individually significant BP increase accompanied by symptoms requires outpatient treatment using oral rapid-onset drugs with an optimal duration of action, in particular captopril. It has a much evidence-based data on the BP increase use and sublingual administration, and also has a favorable safety profile, which allows prescribing to patients with comorbid diseases. The rationale for the use of angiotensin-converting enzyme inhibitor Capoten (captopril) as a drug for self-management of a sudden individually significant BP increase accompanied by symptoms in hypertension patients is describes. 

1. Balanova YA, Shalnova SA, Imaeva AE, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study). Rational Pharmacotherapy in Cardiology. 2019;15(4):450-66. (In Russ.) doi:10.20996/1819-6446-2019-15-4-450-466.

2. Clinical recommendations. Arterial hypertension in adults. Russian medical society for arterial hypertension, 2016. (In Russ.) http://webmed.irkutsk.ru/doc/pdf/fedhypert.pdf

3. Algorithms for managing a patient with arterial hypertension and hypertensive crisis all-Russian public organization “Promoting the prevention and treatment of arterial hypertension “Antihypertensive League”. Saint Petersburg, 2019. First edition. (In Russ.) https://scardio.ru/content/documents/algorythmy.pdf

4. Hypertensive crisis. Edited by S. N. Tereshchenko, N. F. Plavunov. 2nd ed., additional and pererab. M.: Medpress-inform, 2013. 208 р. (In Russ.) ISBN: 978-5-98322-968-6.

5. Clinical practice guidelines hypertension in adults. Russian cardiological society, 2020. (In Russ.) http://cr.rosminzdrav.ru/#!/schema/687

6. Williams B, Mancia G, Spiering W, et al.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-104. doi:10.1093/eurheartj/ehy339.

7. Patel KK, Young L, Howell EH, et al. Characteristics and outcomes of patients presenting with hypertensive urgency. in the office setting. JAMA Intern Med. 2016;176:981-8.

8. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e484-e594. doi:10.1161/CIR.0000000000000596.

9. Peixoto AJ. Acute Severe Hypertension. N Engl J Med. 2019;381:1843-52. doi:10.1056/NEJMcp1901117.

10. Grassi D, O’Flaherty M, Pellizzari M, et al.; Group of Investigators of the REHASE Program. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008;10:662-7. doi:10.1111/j.1751-7176.2008.00001.x.

11. Resolution Of the government of the Russian Federation of 29.12.2007 N 964 “List of potent substances for the purposes of article 234 and other articles of the criminal code of the Russian Federation” (as amended on 26.02.2013). (In Russ.)

12. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328-31. doi:10.1001/jama.1996.03540160050032.

13. Campos CL, Herring CT, Ali AN, et al. Pharmacologic treatment of hypertensive urgency in the outpatient setting: a systematic review. J Gen Intern Med. 2018;33:539-50. doi:10.1007/s11606-017-4277-6.

14. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68:283-97. doi:10.2165/00003495-200868030-00003.

15. van Harten J, Burggraaf K, Danhof M, et al. Negligible sublingual absorption of nifedipine. Lancet. 1987;2(8572):1363-5. doi:10.1016/s0140-6736(87)91258-x.

16. al-Furaih TA, McElnay JC, Elborn JS, et al. Sublingual captopril — a pharmacokinetic and pharmacodynamic evaluation. Eur J Clin Pharmacol. 1991;40:393-8.

17. McElnay JC, Al-Furaih TA, Hughes CM, et al. The effect of pH on the buccal and sublingual absorption of captopril. Eur J Clin Pharmacol. 1995;48:373-9.

18. McElnay JC, Al-Furaih TA, Hughes CM, et al. A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure. Eur J Clin Pharmacol. 1996;49:471-6.

19. Tschollar W, Belz GG. Sublingual captopril in hypertensive crisis. Lancet. 1985 Jul 6;2(8445):34-5.

20. Pose Reino A, Gonzalez-Juanatey JR, Fernandez Velo JL, et al. Sublingual enalapril in hypertensive crisis. A preliminary study. An Med Interna. 1989;6:421-3.

21. Gokel Y, Satar S, Paydaş S. A Comparison of the Effectiveness of Sublingual Losartan, Sublingual Captopril and Sublingual Nifedipine in Hypertensive Urgency. Turk J Med Sci. 1999;29:655-60.

22. Gemici K, Karakoc Y, Ersoy A, et al. A Comparison of Safety and Efficacy of Sublingual Captopril with Sublingual Nifedipine in Hypertensive Crisis. Int J Angiol. 1999 Jun;8(3):147-9.

23. Kazerani H, Hajimoradi B, Amini A, et al. Clinical efficacy of sublingual captopril in the treatment of hypertensive urgency Singapore Med J. 2009;50(4), 400-2.

24. Instructions for use of the medicinal product for medical use Capoten RU no. P013055/01. (In Russ.) Инструкция по применению лекарственного средства для медицинского применения Капотен РУ №П013055/01.

25. Chazova IA, Aksenova AV, Oshchepkova EV. Features of the course of arterial hypertension in men and women (according to the National register of arterial hypertension). Therapeutic archive. 2019;91(1):4-12. (In Russ.)

26. Janashia P. H., Poteshkina N. G. Relationship of structural-functional and electrophysiological remodeling of the myocardium in patients with arterial hypertension. Russian Journal of Cardiology. 2005;(1):28-32. (In Russ.)

27. Getman SI. Characteristics of Disturbances of Heart Rhythm and Conduction Among Patients Attending Consultation of a Cardiologist at Ambulatory Stage. Kardiologiia. 2018;58(6):20-8. (In Russ.)

28. ONTARGET Investigators. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England journal of medicine. 2008;358,15:1547-59. doi:10.1056/NEJMoa0801317.

29. Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. The New England journal of medicine. 2012;367,23:2204-13. doi:10.1056/NEJMoa1208799.

30. Tkacheva ON, Runikhina NK, Kotovskaya YuV, et al. Treatment of arterial hypertension in patients 80 years and older and patients with senile asthenia. Journal for continuing medical education of physicians. Cardiology: news, opinions, training. 2017;2:76-90. (In Russ.)

31. Marigliano V, Santilli D, Fiorani M, et al. Hypertensive emergencies in old age: effects of angiotensin converting enzyme inhibition. J Hypertens Suppl. 1988 Nov;6(1):S91-3.

32. Salkic S, Brkic S, Batic-Mujanovic O, et al. Emergency Room Treatment of Hypertensive Crises. Med Arch. 2015 Oct;69(5):302-6. doi:10.5455/medarh.2015.69.302-306.

33. https://forta.umm.uni-heidelberg.de/ , дата доступа 28.01.2020.

34. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227-46. doi:10.1111/jgs.13702.

35. Alshami A, Romero C, Avila A, Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504-12. doi:10.11909/j.issn.1671-5411.2018.07.007.

36. https://www.gov.spb.ru/gov/terr/reg_viborg/news/61532/ доступ 28.01.2020.

37. https://www.tfoms22.ru/doc/2017/ALGORITMY-NEOTLOZhNOJ-POMOShhI.pdf доступ 28.01.2020.